Teladoc and Livongo Slide as Investors Balk at Proposed Deal (2)

Aug. 5, 2020, 5:11 PM

Teladoc Health Inc., a U.S. supplier of virtual health care, agreed to buy Livongo Health Inc., which helps manage diabetes with connected devices, for about $18.5 billion, as the novel coronavirus pandemic spurs demand for remote medicine.

The deal will allow Teladoc to expand into management of chronic conditions and give the company access to Livongo’s glucose monitors and smart scales that it sends to the members in its programs in order to track their biometric data.

“This is the next logical step for us,” said Jason Gorevic, Teladoc’s chief executive officer. “A year ago, I wouldn’t ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.